VNS in drug resistant epilepsy: preliminary report on a small group of patients

BACKGROUND: In 1997 Vagus Nerve Stimulation (VNS) received approval from the US Food and Drug Administration (FDA) as an adjunctive therapy in the treatment of medically intractable partial epilepsy in people aged 12 years and older who are ineligible for resective epilepsy surgery. Although the exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzoni, Emilio, Gentile, Valentina, Colonnelli, Maria Chiara, Brunetto, Daniela, Cecconi, Ilaria, Iero, Luisa, Moscano, Filomena C, Cordelli, Duccio M, Marchiani, Valentina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859348/
https://www.ncbi.nlm.nih.gov/pubmed/20398284
http://dx.doi.org/10.1186/1824-7288-36-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859348/
https://www.ncbi.nlm.nih.gov/pubmed/20398284
http://dx.doi.org/10.1186/1824-7288-36-30

Ejemplares similares